The vehicle that an increasing number of companies are using to go public, called a special purpose acquisition company (SPAC), is billed on Wall Street as a streamlined way to list and attract investors. It’s a chief reason the number of IPOs surged to 480 last year from 233 in 2019, according to Securities and […]

Cancer is the second leading cause of death worldwide, so the theory of preventing it before it occurs makes a lot of sense. The global cancer vaccines market stood at $5.68 billion in 2019 and was projected to grow to $24.32 billion by 2030. Here are just a few of the companies trying to make […]

After a record year for biotech IPOs in 2020, forecasts were bullish on another strong year showing for public offerings — and 2021 hasn’t disappointed so far. Now, a clutch of four biotechs chasing rare disease and cancer and a New York SPAC are ready to join the party. Three more companies filed to head […]